PETER CONTI

Profile

First Name

: PETER

Middle Name

:

Last Name

: CONTI

Filings
Filing Date
Filing Type
Source URL
Industry Classifier
Detailed Industry
Revenue Range
Securities
First Sale Date
2020-09-15
D
Link
OTHER 
 
DECLINE TO DISCLOSE 
Equity 
2020-08-28 
2019-07-12
D
Link
BIOTECHNOLOGY 
 
DECLINE TO DISCLOSE 
Equity 
2019-06-28 
2019-06-10
D
Link
BIOTECHNOLOGY 
 
DECLINE TO DISCLOSE 
 
2019-05-28 
2019-05-31
D
Link
BIOTECHNOLOGY 
 
DECLINE TO DISCLOSE 
Debt 
2019-05-16 
2018-10-16
D/A
Link
BIOTECHNOLOGY 
 
DECLINE TO DISCLOSE 
Equity 
2018-06-18 
2018-07-03
D
Link
BIOTECHNOLOGY 
 
DECLINE TO DISCLOSE 
Equity 
2018-06-18 
2017-12-18
D
Link
BIOTECHNOLOGY 
 
DECLINE TO DISCLOSE 
Debt 
2017-12-01 
2017-11-15
D/A
Link
BIOTECHNOLOGY 
 
NO REVENUES 
 
2017-06-16 
2017-06-30
D
Link
BIOTECHNOLOGY 
 
NO REVENUES 
 
2017-06-16 
2017-02-06
D/A
Link
BIOTECHNOLOGY 
 
NO REVENUES 
Equity 
2015-11-20 
2015-12-07
D
Link
BIOTECHNOLOGY 
 
NO REVENUES 
Equity 
2015-11-20 
2015-01-06
D
Link
PHARMACEUTICALS 
 
NO REVENUES 
Equity 
2014-12-22 
2013-09-27
D
Link
PHARMACEUTICALS 
IN VITRO + IN VIVO DIAGNOSTIC SUBSTANCES [2835] 
DECLINE TO DISCLOSE 
Equity, Debt 
2013-09-18 
2013-07-08
D
Link
PHARMACEUTICALS 
IN VITRO + IN VIVO DIAGNOSTIC SUBSTANCES [2835] 
DECLINE TO DISCLOSE 
Debt 
2013-06-21 
2012-11-21
D
Link
PHARMACEUTICALS 
IN VITRO + IN VIVO DIAGNOSTIC SUBSTANCES [2835] 
DECLINE TO DISCLOSE 
Equity 
2012-11-19